MASS Valuation

908 Devices Inc

Add to Watchlist

Advanced Chart

5.520

-0.42(-7.071%)1D

Overview
Forecast
Valuation
Earnings

MASS Relative Valuation

MASS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MASS is overvalued; if below, it's undervalued.

Historical Valuation

908 Devices Inc (MASS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.41 is considered Undervalued compared with the five-year average of -21.44. The fair price of 908 Devices Inc (MASS) is between 39.55 to 41.30 according to relative valuation methord. Compared to the current price of 5.68 USD , 908 Devices Inc is Undervalued By 85.64%.

Relative Value

Fair Zone

39.55-41.30

Current Price：5.68

85.64%

Undervalued

-19.94

Trailing

Forward

-17.95

EV/EBITDA

908 Devices Inc. (MASS) has a current EV/EBITDA of -17.95. The 5-year average EV/EBITDA is -21.86. The thresholds are as follows: Strongly Undervalued below -84.76, Undervalued between -84.76 and -53.31, Fairly Valued between 9.58 and -53.31, Overvalued between 9.58 and 41.03, and Strongly Overvalued above 41.03. The current Forward EV/EBITDA of -17.95 falls within the Historic Trend Line -Fairly Valued range.

-11.83

EV/EBIT

908 Devices Inc. (MASS) has a current EV/EBIT of -11.83. The 5-year average EV/EBIT is -18.89. The thresholds are as follows: Strongly Undervalued below -74.21, Undervalued between -74.21 and -46.55, Fairly Valued between 8.77 and -46.55, Overvalued between 8.77 and 36.43, and Strongly Overvalued above 36.43. The current Forward EV/EBIT of -11.83 falls within the Historic Trend Line -Fairly Valued range.

4.41

908 Devices Inc. (MASS) has a current PS of 4.41. The 5-year average PS is 10.05. The thresholds are as follows: Strongly Undervalued below -10.26, Undervalued between -10.26 and -0.10, Fairly Valued between 20.21 and -0.10, Overvalued between 20.21 and 30.36, and Strongly Overvalued above 30.36. The current Forward PS of 4.41 falls within the Historic Trend Line -Fairly Valued range.

62.22

P/OCF

908 Devices Inc. (MASS) has a current P/OCF of 62.22. The 5-year average P/OCF is -18.96. The thresholds are as follows: Strongly Undervalued below -66.46, Undervalued between -66.46 and -42.71, Fairly Valued between 4.79 and -42.71, Overvalued between 4.79 and 28.55, and Strongly Overvalued above 28.55. The current Forward P/OCF of 62.22 falls within the Strongly Overvalued range.

41.48

P/FCF

908 Devices Inc. (MASS) has a current P/FCF of 41.48. The 5-year average P/FCF is -8.99. The thresholds are as follows: Strongly Undervalued below -39.74, Undervalued between -39.74 and -24.37, Fairly Valued between 6.39 and -24.37, Overvalued between 6.39 and 21.77, and Strongly Overvalued above 21.77. The current Forward P/FCF of 41.48 falls within the Strongly Overvalued range.

908 Devices Inc (MASS) has a current Price-to-Book (P/B) ratio of 1.56. Compared to its 3-year average P/B ratio of 1.31 , the current P/B ratio is approximately 19.47% higher. Relative to its 5-year average P/B ratio of 3.11, the current P/B ratio is about -49.65% higher. 908 Devices Inc (MASS) has a Forward Free Cash Flow (FCF) yield of approximately -14.37%. Compared to its 3-year average FCF yield of -16.14%, the current FCF yield is approximately -10.96% lower. Relative to its 5-year average FCF yield of -10.80% , the current FCF yield is about 33.10% lower.

1.56

P/B

Median3y

1.31

Median5y

3.11

-14.37

FCF Yield

Median3y

-16.14

Median5y

-10.80

Competitors Valuation Multiple

The average P/S ratio for MASS's competitors is 131.66, providing a benchmark for relative valuation. 908 Devices Inc Corp (MASS) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 58.68%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Alpha Tau Medical Ltd

Profound Medical Corp

Performance Decomposition

Market capitalization of MASS increased by 59.08% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 7.42M to 11.78M.

The secondary factor is the Margin Expansion, contributed 5.16%to the performance.

Overall, the performance of MASS in the past 1 year is driven by Revenue Growth. Which is more sustainable.

58.68%

7.42M → 11.78M

Revenue Growth

5.16%

-79.43 → -83.53

Margin Expansion

-4.76%

-3.34 → -3.18

P/E Change

59.08%